Literature DB >> 7528464

Impaired endothelium-dependent vascular relaxation in patients with hypercholesterolemia extends beyond the muscarinic receptor.

P R Casino1, C M Kilcoyne, R O Cannon, A A Quyyumi, J A Panza.   

Abstract

Patients with hypercholesterolemia have impaired endothelium-dependent vasodilation. However, previous human studies have invariably used muscarinic agents to assess endothelial function. The purpose of this investigation was to determine whether impaired endothelium-dependent vasodilation of hypercholesterolemic patients is related to a specific and isolated defect of the muscarinic receptor, or to a broader abnormality of the endothelial cells. The forearm vascular responses to the endothelium-dependent agents acetylcholine (7.5, 15, and 30 micrograms/min) and substance P (1, 2, and 4 pmol/min), and to the direct smooth muscle dilator sodium nitroprusside (0.8, 1.6, and 3.2 micrograms/min) were studied in 16 hypercholesterolemic patients (8 men and 8 women; age [mean +/- SD] 50 +/- 7 years; serum cholesterol > 250 mg/dl) and 16 normal volunteers (8 men and 8 women; age 47 +/- 8 years; serum cholesterol < 200 mg/dl). Drugs were infused into the brachial artery and the response of the forearm vasculature was measured by strain-gauge plethysmography. The vasodilator response to acetylcholine was reduced in hypercholesterolemic patients compared with normal controls; at the highest dose (30 micrograms/min) the increase in forearm blood flow was 13.5 +/- 7 ml/min/100 ml in controls and 7.54 +/- 6 in patients (p < 0.05). The response to substance P was also blunted in hypercholesterolemic patients; at the highest dose (4 pmol/min), the increase in forearm blood flow was 12.1 +/- 5 ml/min/100 ml in controls and 7.6 +/- 4 in patients (p < 0.03). A significant correlation was found between the highest blood flow responses with acetylcholine and with substance P (r = 0.58; p < 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7528464     DOI: 10.1016/s0002-9149(99)80524-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  Hypercholesterolaemia and lipid lowering treatment do not affect the acute endogenous fibrinolytic capacity in vivo.

Authors:  D E Newby; F N Witherow; R A Wright; P Bloomfield; C A Ludlam; N A Boon; K A A Fox; D J Webb
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

2.  Nitric oxide-mediated endothlium-dependent vasodilation is impaired with borderline high-LDL cholesterol.

Authors:  Kyle J Diehl; Brian L Stauffer; Jared J Greiner; Brian R Weil; Christopher A DeSouza
Journal:  Clin Transl Sci       Date:  2012-02-23       Impact factor: 4.689

3.  Rabbit aortic endothelial dysfunction by low-density lipoprotein is attenuated by L-arginine, L-ascorbate and pyridoxine.

Authors:  Yong Ji; Yi Han; Jianxin Diao; Yan Huang; Qi Chen; Albert Ferro
Journal:  Br J Pharmacol       Date:  2003-11-03       Impact factor: 8.739

4.  Impaired endothelium-dependent vasodilation in overweight and obese adult humans is not limited to muscarinic receptor agonists.

Authors:  Gary P Van Guilder; Brian L Stauffer; Jared J Greiner; Christopher A Desouza
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-02-15       Impact factor: 4.733

5.  Evidence for agonist-specific endothelial vasodilator dysfunction with ageing in healthy humans.

Authors:  Christopher A DeSouza; Christopher M Clevenger; Jared J Greiner; Derek T Smith; Greta L Hoetzer; Linda F Shapiro; Brian L Stauffer
Journal:  J Physiol       Date:  2002-07-01       Impact factor: 5.182

6.  Effects of ageing and regular aerobic exercise on endothelial fibrinolytic capacity in humans.

Authors:  Derek T Smith; Greta L Hoetzer; Jared J Greiner; Brian L Stauffer; Christopher A DeSouza
Journal:  J Physiol       Date:  2003-01-01       Impact factor: 5.182

7.  Enhanced K(+)-channel-mediated endothelium-dependent local and conducted dilation of small mesenteric arteries from ApoE(-/-) mice.

Authors:  Timea Beleznai; Hiromichi Takano; Claire Hamill; Polina Yarova; Gillian Douglas; Keith Channon; Kim Dora
Journal:  Cardiovasc Res       Date:  2011-06-20       Impact factor: 10.787

Review 8.  Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome.

Authors:  Hadi A R Hadi; Cornelia S Carr; Jassim Al Suwaidi
Journal:  Vasc Health Risk Manag       Date:  2005

9.  Nitric oxide function in atherosclerosis.

Authors:  K E Matthys; H Bult
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.